Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia

Genes, Chromosomes & Cancer
R JamalY Hayashi

Abstract

Tandem duplication (TD) of the MLL or FLT3 gene in acute myeloid leukemia (AML) has been reported. We examined whether TD of these two genes occurs simultaneously. We analyzed 13 AML and 2 myelodysplastic syndrome patients, including 6 adult patients with trisomy 11 and 9 pediatric patients with TD of the FLT3 gene, using RT-PCR followed by sequencing. Among these, TD of the MLL and FLT3 genes was found in 5 and 10 patients, respectively. Notably, TD of both the MLL and FLT3 genes (coduplication) was detected in two AML patients, who died 6 and 14 months after diagnosis. TD of these two genes in AML is rare; thus, coduplication of these genes in the same patient is predicted to be very rare. Although the mechanisms of TD of both genes are different, development of TD of both genes may be related to an unknown similar etiology in leukemia because the frequency of coduplication of these genes in a single patient is considered to be very low. Further studies of the coduplication of these genes in AML patients may lead to the clarification of its mechanism and clinical implications.

References

Jun 1, 1995·Genes, Chromosomes & Cancer·O A Bernard, R Berger
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·S A SchichmanC M Croce
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·M P StroutM A Caligiuri
Feb 3, 1999·Annual Review of Genetics·J D Rowley
Aug 5, 2000·Genes, Chromosomes & Cancer·L MichauxA Hagemeijer

❮ Previous
Next ❯

Citations

Jun 4, 2002·Current Opinion in Hematology·D Gary Gilliland, James D Griffin
Oct 2, 2007·Current Opinion in Oncology·Olga FrankfurtMartin S Tallman
Aug 27, 2002·Annual Review of Genomics and Human Genetics·Louise M Kelly, D Gary Gilliland
Jan 6, 2004·International Journal of Hematology·Yasuhide Hayashi
May 17, 2003·Leukemia·H QuentmeierH G Drexler
Sep 13, 2003·Leukemia·M Levis, D Small
Sep 9, 2005·International Journal of Hematology·Hitoshi KiyoiKazutaka Ozekia
Aug 15, 2002·Blood·D Gary Gilliland, James D Griffin
Jun 26, 2014·International Journal of Hematology·Hideki NakayamaSouichi Adachi
Aug 6, 2003·British Journal of Haematology·Panagiotis D KottaridisDavid C Linch
Dec 3, 2010·Critical Reviews in Oncology/hematology·Francesco MarchesiGiuseppe Avvisati

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.